Source comparison
TB-500 Studied Muscle Tear: Research vs Clinical Application
Equine (2019, J Appl Physiol) 20mg twice weekly × 4 weeks Surgically induced gastrocnemius tear 34% faster return to baseline contractile function Small sample size (n=12), single injury type Rodent (2016, PLOS ONE) 6mg/kg twice weekly × 3 weeks Chemically ind
This comparison does not assign a generated winner or score.
- Equine (2019, J Appl Physiol)
- 20mg twice weekly × 4 weeks
- Surgically induced gastrocnemius tear
- 34% faster return to baseline contractile function
- Small sample size (n=12), single injury type
- Rodent (2016, PLOS ONE)
- 6mg/kg twice weekly × 3 weeks
- Chemically induced contusion
- 47% higher capillary density, 38% greater tensile strength
- Rodent healing kinetics differ from humans
- Equine (2021, Vet J)
- 10mg twice weekly × 6 weeks
- Naturally occurring tendon injuries
- 52% reduction in re-injury rate over 12 months
- Observational design, no placebo control
- In Vitro (2018, Cell Tissue Res)
- 10–100ng/mL culture media
- Human myoblast scratch assay
- 2.3× faster wound closure, increased MMP-2 expression
- In vitro models lack systemic complexity